Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT

Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT

Background: Injectable hydrogels have great promise in the treatment of myocardial infarction (MI); however, the lack of electromechanical coupling of the hydrogel to the host myocardial tissue and the inability to monitor the implantation may compromise a successful treatment. The introduction of c...

Full description

Bibliographic Details
Main Authors: Jiang, D. (Author), Lan, X. (Author), Qian, R. (Author), Qin, C. (Author), Shao, F. (Author), Wang, K. (Author), Zheng, D. (Author), Zhu, K. (Author), Zhu, Z. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Cardiology
Cell culture
Conductive hydrogel
Crosslinking
Flowcharting
Gold
Gold nanorod
Gold nanorods
Hydrogels
Mesenchymal stem cell
Mesenchymal stem cells
Myocardial infarction
Myocardial Infarction
Nanocomposite hydrogels
Nanocomposites
Nanoplatelet
Nanorods
Poly lactide-co-glycolide
Polyethylene glycols
Polylactide-co-glycolide
Poly-lactide-co-glycolide
Positive ions
Positron emission tomography
Positron emission tomography (PET)
Rats
Silicates
Stem cells
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items